XML 28 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
Collaboration and License Agreements (Details)
1 Months Ended 12 Months Ended
Oct. 31, 2014
USD ($)
Oct. 31, 2014
EUR (€)
Jul. 31, 2005
USD ($)
Dec. 31, 2014
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions        
Ipsen Upfront Payment $ 23,000,000lxrx_IpsenUpfrontPayment      
Ipsen Revenue Allocated to Development Deliverable 1,600,000lxrx_IpsenRevenueAllocatedtoDevelopmentDeliverable      
Ipsen Revenue Allocated to Committee Deliverable 100,000lxrx_IpsenRevenueAllocatedtoCommitteeDeliverable      
Ipsen Revenue Allocated to License Deliverable 21,200,000lxrx_IpsenRevenueAllocatedtoLicenseDeliverable      
Ipsen Revenue Recognized       21,400,000lxrx_IpsenRevenueRecognized
Ipsen Maximum Regulatory And Commercial Milestones 30,000,000lxrx_IpsenMaximumRegulatoryAndCommercialMilestones      
Ipsen Maximum Sales Milestones   72,000,000lxrx_IpsenMaximumSalesMilestones    
TX Enterprise Fund Award     35,000,000lxrx_TxEnterpriseFundAward  
TX Enterprise Fund Award to Texas AM University System     15,000,000lxrx_TxEnterpriseFundAwardToTexasAmUniversitySystem  
TIGM Per Job Payment Amount       2,415lxrx_TigmPerJobPaymentAmount
TIGM Maximum Exposure       14,200,000lxrx_TigmMaximumExposure
TIGM Maximum Exposure Through Reporting Date       $ 2,500,000lxrx_TIGMMaximumExposureThroughReportingDate